Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,324
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,859
Class I recallsReasonable probability of serious health consequences
24,440
Class II recallsTemporary or medically reversible health consequences
2,900
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,095 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,739 recalls have been announced year to date.
  • Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (300).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,440
Class I9,859
Class III2,900
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,440
Class I9,859
Class III2,900
Not Yet Classified2

Showing 4,501–4,520 of 20,511 recalls

FDA Recall United States TerminatedTerminated: May 3, 2023Historical recordClass II

Wismettac Asian Foods, Inc.

Product
Chili Pepper Powder (ICHIMI TOGARASHI) 300g UPC: 07441034116…
Reason
Product was found to contain sesame that were not declared on the ingredient label.
Published
March 15, 2023
Distribution
Nationwide

View recall →

FDA Recall United States TerminatedTerminated: March 13, 2023Historical recordClass III

4 Earth Farms formerly Mcl Fresh Inc

Product
Brussel Sprouts 98.5% of product was packaged for retail and…
Reason
Organic Brussel Sprouts tested positive for Chlorpyrifos by the State of California
Published
March 15, 2023
Distribution
California, Connecticut, Florida, Illino…

View recall →

FDA Recall United States TerminatedTerminated: December 6, 2023Historical recordClass II

Ebenezer Ethio Market, LLC.

Product
Elsa kolo Yegbes Kolo Belewez
Reason
Product was not properly labeled in English for importing into the US and filth was found in product (including mold, hair, bird feather, yarn).
Published
March 15, 2023
Distribution
MN

View recall →

FDA Recall TerminatedTerminated: April 30, 2024Historical recordClass II

Carbidopa and Levodopa Tablets, USP 25 mg/100 mg, 10x10 Unit Dose carton, Rx Only, Manufactured in Czech Republic by: Teva Czech Industries, s.r.o. Opava-Komarov, Czech Republic, Manufactured for: Teva Pharmaceuticals USA, Inc. Parsippany, NJ 07054, Packaged and Distributed by: Major Pharmaceuticals Indianapolis, IN 46268 USA. NDC 0904-7257-61, UPC 3 09047 25761 4

by The Harvard Drug Group

Reason
Packaging defect: observed packaging defect, blister packaging inadequately sealed.
Published
March 8, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 21, 2023Historical recordClass III

Fentanyl 1,500 mcg/30 mL syringe, Injection for Intravenous Use, Concentration = 50 mcg/mL, Preservative Free, Rx Only, Single Dose Container, SCA Pharmaceuticals, Windsor CT 06095, NDC# 70004-0200-16.

by SCA Pharmaceuticals

Reason
Subpotent Drug
Published
March 8, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 24, 2024Historical recordClass II

Phenylephrine HCl in 0.9% Sodium Chloride Injection, USP, 50 mg/250 mL (200 mcg/mL), 250 mL Single-Dose Container bottle, packaged in 15 x 1 IV Bottles per carton, Rx Only, Nephron 503B Outsourcing Facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC 69374-321-25.

by Nephron Sterile Compounding Center LLC

Reason
Lack of Assurance of Sterility
Published
March 8, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 24, 2024Historical recordClass II

Phenylephrine HCl Injection, USP, 0.8 mg/10 mL (80 mcg/mL), 10 mL Single-Dose Vial, packaged in 30 x 10 mL Single-Dose Vials per carton, 12 x 30 Vials Carton per case, Rx Only, Nephron 503B Outsourcing Facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC 69374-301-10.

by Nephron Sterile Compounding Center LLC

Reason
Lack of Assurance of Sterility
Published
March 8, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 24, 2024Historical recordClass II

Phenylephrine HCl Injection, USP, 0.4 mg/10 mL (40 mcg/mL), 10 mL Single-Dose Vial, packaged in 30 x 10 mL Single-Dose Vials per carton, 12 x 30 Vials Carton per case, Rx Only, Nephron 503B Outsourcing Facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC 69374-305-10.

by Nephron Sterile Compounding Center LLC

Reason
Lack of Assurance of Sterility
Published
March 8, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 24, 2024Historical recordClass II

Phenylephrine HCl Injection, USP, 1 mg/10 mL (100 mcg/mL), 10 mL Single-Dose Vial, packaged in 30 x 10 mL Sterile Single-Dose Vials per carton, 12 x 30 Vials Carton per case, Rx Only, Nephron 503B Outsourcing Facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC 69374-302-10.

by Nephron Sterile Compounding Center LLC

Reason
Lack of Assurance of Sterility
Published
March 8, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 24, 2024Historical recordClass II

Norepinephrine Bitartrate in 0.9% Sodium Chloride Injection, USP, 16 mg/250 mL (64 mcg/mL*), 250 mL Single-Dose Container bottle, packaged in 15 IV Bottles per carton, Rx Only, Nephron 503B Outsourcing Facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC 69374-315-25.

by Nephron Sterile Compounding Center LLC

Reason
Lack of Assurance of Sterility
Published
March 8, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 24, 2024Historical recordClass II

Norepinephrine Bitartrate in 0.9% Sodium Chloride Injection, USP, 4 mg/250 mL (16 mcg/mL*), 250 mL Single-Dose Container bottle, packaged in 15 IV Bottles per carton, Rx Only, Nephron 503B Outsourcing Facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC 69374-319-25.

by Nephron Sterile Compounding Center LLC

Reason
Lack of Assurance of Sterility
Published
March 8, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 24, 2024Historical recordClass II

Norepinephrine Bitartrate in 0.9% Sodium Chloride Injection, USP, 8 mg/250 mL (32 mcg/mL*), 250 mL Single-Dose Container, packaged in 15 x 1 IV Bottles per carton, Rx Only, Nephron 503B Outsourcing Facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC 69374-316-25.

by Nephron Sterile Compounding Center LLC

Reason
Lack of Assurance of Sterility
Published
March 8, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 24, 2024Historical recordClass II

Diltiazem HCl in 0.7% Sodium Chloride Injection, 125 mg/125 mL (1 mg/mL), 125 mL Single-Dose Container bottle, packaged in 15 x 1 IV Bottles per carton, Rx Only, Nephron 503B Outsourcing Facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC 69374-997-15.

by Nephron Sterile Compounding Center LLC

Reason
Lack of Assurance of Sterility
Published
March 8, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 20, 2023Historical recordClass III

Avicel PH-200 NF, Microcrystalline Cellulose, NF, Ph. Eur., Jp, Net Content/Gross Weight 20.0 KG / 21.1 KG bulk container, Manufactured by: DuPont Nutrition USA, Inc., 1301 Ogletown Road, Newark, DE 19711, USA. Headquarters: DuPont Nutrition Biosciences ApS, Langebrogade 1, Copenhagen, Denmark

by DuPont Nutrition USA, Inc

Reason
Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
Published
March 8, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 20, 2023Historical recordClass III

Avicel PH- 102 NF, Microcrystalline Cellulose, NF, Ph. Eur., Jp, Net Content/Gross Weight 20.0 KG / 21.1 KG bulk container, Manufactured by: DuPont Nutrition USA, Inc., 1301 Ogletown Road, Newark, DE 19711, USA. Headquarters: DuPont Nutrition Biosciences ApS, Langebrogade 1, Copenhagen, Denmark

by DuPont Nutrition USA, Inc

Reason
Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
Published
March 8, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 20, 2023Historical recordClass III

Avicel PH- 101 NF, Microcrystalline Cellulose, NF, Ph. Eur., Jp. Net Content/Gross Weight 50.0 KG / 54.5 KG bulk container, Manufactured by: DuPont Nutrition USA, Inc., 1301 Ogletown Road, Newark, DE 19711, USA. Headquarters: DuPont Nutrition Biosciences ApS, Langebrogade 1, Copenhagen, Denmark

by DuPont Nutrition USA, Inc

Reason
Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
Published
March 8, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 20, 2024Historical recordClass I

PrimeZEN Black 6000 capsule, 2000mg, Male Sexual Performance Enhancement, 1-count blister card, Distributed by: Prime Premier Group, Los Angeles, CA 90006, UPC 7 28175 52189 1.

by Volt Candy Wholesale Club

Reason
Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Published
March 8, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 17, 2024Historical recordClass III

Gabapentin Tablets, USP 600 mg, 500 tablets per bottle, RX Only, Manufactured by ScieGen Pharmaceuticals Inc., Hauppauge, NY 11788, NDC: 50228-177-05.

by Sciegen Pharmaceuticals Inc

Reason
Presence of Foreign Tablets/Capsules: Pharmacist reported presence of some Gabapentin tablets 800 mg comingled in Gabapentin 600 mg 500 count bottles.
Published
March 8, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: March 18, 2024Historical recordClass II

Levothyroxine Sodium Tablets, USP 112 mcg, 90 tablets per bottle, Rx Only, Manufactured by Lloyd Inc., Shenandoah, IA, 51601, Distributed by: Alvogen Inc, Pine Brook, NJ 07058, NDC 47781-654-90.

by Alvogen, Inc

Reason
Sub-Potent Drug: Out of specification for assay at the 24 month interval.
Published
March 8, 2023
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 20, 2023Historical recordClass III

BD-102 NF, Microcrystalline Cellulose, NF, Ph. Eur., Jp., Net Content/Gross Weight 20.0 KG / 21.1 KG bulk container, Manufactured by: DuPont Nutrition USA, Inc., 1301 Ogletown Road, Newark, DE 19711, USA. Headquarters: DuPont Nutrition Biosciences ApS, Langebrogade 1, Copenhagen, Denmark

by DuPont Nutrition USA, Inc

Reason
Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
Published
March 8, 2023
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.